Philip practised as a technology transactions lawyer for 30 years before stepping back from private practice in 2013. As a practitioner, Philip represented universities, research institutes, start up companies, venture capital firms, SMEs, publicly listed companies, multinational companies, and Australian and foreign governments in their technology transactions. He is presently an Adjunct Professor at Queensland University of Technology, where he lectures on the Management and Commercialisation of IP in the QUT-WIPO Masters of Intellectual Property Law program. Philip has led or been a member of the transactions teams negotiating numerous global IP licenses, strategic alliances, joint ventures, collaborations, and IP mergers and acquisitions, across all technology sectors including pharmaceutical, biotechnology, medical devices, ICT, materials and chemical engineering, etc. He has negotiated technology transactions with parties in over 20 countries, from large multi-national companies, to small companies, and with government parties. He has undertaken what have been some of the largest technology transactions emerging from Australian research, measured in a number of respects including:
- deal value
- number of lives saved by new therapeutic and prophylactic products, and
- export revenue generated.